G. Vandenbosch et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) COUNTERACTSTHE INHIBITING EFFECT OF MONOCYTES ON NATURAL-KILLER (NK) CELLS, Clinical and experimental immunology, 101(3), 1995, pp. 515-520
GM-CSF is known to accelerate haematopoietic recovery following alloge
neic bone marrow transplantation (BMT). In addition, it may restore an
d enhance both granulocyte and monocyte functions. Stimulation of mono
cyte functions may induce a direct or an indirect anti-leukaemic activ
ity due to an increase of cellular cytotoxicity and production of cyto
kines which may result in a reduction of the relapse rate after BMT. N
K cells may play a crucial role in this activity. Therefore we studied
the influence of monocytes on NK activity in combination with GM-CSF.
Lymphocytes and monocytes were isolated from buffy coats of healthy i
ndividuals by counterflow centrifugation elutriation (CCE). NK activit
y was exerted by CD3(-)CD56(+) cell populations and could be enhanced
by IL-2 incubation overnight. Incubation of CD3(-)CD56(+) cells with G
M-CSF in the presence or absence of IL-2 hardly influenced NK activity
of the lymphocyte population. Low amounts of monocytes enhanced NK ac
tivity. NK activity in lymphocyte population in the presence of equiva
lent numbers of monocytes with or without IL-2 was strongly decreased
irrespective of the effector:target ratio (ETR). This appeared not to
result from sterical hindrance effects of the present number of cells.
However, addition of GM-CSF abrogated the inhibition of NK activity b
y monocytes in the presence of IL-2. In monocyte fractions neither IL-
2 nor GMCSF yielded NK activity. Our findings indicate that GM-CSF can
affect NK activity by counteracting the suppressing effects of monocy
tes, and hence may improve the outcome after BMT.